SCREENING OF A NEW DRUG BDF 8503 FOR ANY ANTIHISTAMINIC EFFECT: COMPARISON OF THE PA2 OF A KNOWN HISTAMINE RECEPTOR ANTAGONIST, MEPYRAMINE, WITH THAT OF BDF 8503

SCREENING OF A NEW DRUG BDF 8503 FOR ANY ANTIHISTAMINIC EFFECT: COMPARISON OF THE PA2 OF A KNOWN HISTAMINE RECEPTOR ANTAGONIST, MEPYRAMINE, WITH THAT OF BDF 8503

TABLE OF CONTENT
Title page
Certification page
Dedication page
Acknowledgement
Abstract
Table of content

CHAPTER ONE
1.0 INTRODUCTION
1.1 Background of the project
1.2 statement of problem
1.3 purpose of the project
1.4 Justification
1.5 scope of the project
1.6 limitation of the project
1.7 project report organization
1.8 Definition of terms

CHAPTER TWO
2.0 LITERATURE REVIEW

CHAPTER THREE
3.0 SYSTEM ANALYSIS AND DESIGN
3.1 Methodology
3.2 Data collection
3.2.1 Methods of Data Collection
3.2.2 Input analysis
3.2.6 Output Analysis
3.3 Analysis of the Existing System
3.4 Limitations of the Existing System
3.4.1Justification for the new system
3.5 System Design
3.5.1 Output Specification and Design
3.5.2 Input Design and Specification
3.6 Database Design
3.7 Program Design and Specification
3.7.4 Change Password

CHAPTER FOUR
4.0 IMPLEMENTATION, TESTING AND INTEGRATION
4.1 Choice of Development Tools
4.2 System Requirement
4.2.1 Software Requirements
4.2.2 Hardware Requirements
4.2.3 People Ware (Personal Requirements)
4.3 system Implementation
4.4 Program Flowchart
4.5 Testing
4.5.1Unit testing
4.5.2 System testing

CHAPTER FIVE
5.0 SUMMARY, CONCLUSION AND RECOMMENDATIONS
5.1 Summary of findings
5.2 limitations of the study/project
5.3 Recommendation
5.5 Conclusion
References

SCREENING OF A NEW DRUG BDF 8503 FOR ANY ANTIHISTAMINIC EFFECT: COMPARISON OF THE PA2 OF A KNOWN HISTAMINE RECEPTOR ANTAGONIST, MEPYRAMINE, WITH THAT OF BDF 8503